Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700025E21Rik Inhibitors

1700025E21Rik Inhibitors refers to a group of compounds designed to interact with the protein encoded by the gene 1700025E21Rik. Given the limited information about the specific biological role and molecular interactions of 1700025E21Rik, this class of inhibitors is more conceptual than concrete. These inhibitors encompass a wide range of chemical structures and properties, each tailored to modulate the activity of the 1700025E21Rik protein within a cellular context. The mode of action of these inhibitors vary significantly, ranging from direct binding to the protein, altering its structural conformation, to modulating its enzymatic activity or its interaction with other cellular molecules. The diversity in their mechanisms reflects the complexity of protein functions and the intricacies of cellular biochemical networks. Given the presumed functions of 1700025E21Rik, these inhibitors might target various aspects of the protein's activity, such as its involvement in specific signaling pathways, its role in cellular metabolic processes, or its interaction with DNA, RNA, or other proteins.

The development and study of 1700025E21Rik Inhibitors represent a substantial scientific undertaking, bridging molecular biology, chemistry, and computational biology. Researchers would likely use computational methods to model the protein structure of 1700025E21Rik, identifying potential binding sites for inhibitors. The synthesis of these molecules would involve advanced techniques in synthetic chemistry, aiming to create compounds ranging from small molecules to larger, more complex structures. Subsequent experimental validation in biochemical assays and cellular studies would be crucial to determine the actual impact of these inhibitors on the protein's function. This exploration would be iterative, requiring ongoing refinement of both the inhibitors and the understanding of the protein's role in the cell. Such a venture is pivotal not only for grasping the characteristics of these inhibitors but also for deepening our understanding of the biological functions of the 1700025E21Rik protein.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A kinase inhibitor, possibly affecting phosphorylation processes relevant to 1700025E21Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, potentially impacting signaling pathways that 1700025E21Rik might be involved in.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor, could affect cell growth and autophagy pathways, possibly relevant to 1700025E21Rik.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

HDAC inhibitor, might influence gene expression and chromatin remodeling linked to 1700025E21Rik.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibitor of the MAPK/ERK pathway, potentially affecting signaling pathways involving 1700025E21Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor, could impact stress response pathways potentially involving 1700025E21Rik.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, potentially impacting stress response and apoptosis pathways linked to 1700025E21Rik.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, could impact various signaling pathways potentially involving 1700025E21Rik.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor, possibly influencing protein degradation pathways related to 1700025E21Rik.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$58.00
$170.00
15
(1)

Calcium channel blocker, potentially affecting calcium signaling pathways relevant to 1700025E21Rik.